Cart
sales@molnova.com
H-Ala-Ala-Tyr-OH (TFA)
CAS No. ———
H-Ala-Ala-Tyr-OH (TFA)( ——— )
Catalog No. M40625 CAS No. ———
H-Ala-Ala-Tyr-OH TFA can be synthesized mutant peptides.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameH-Ala-Ala-Tyr-OH (TFA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-Ala-Ala-Tyr-OH TFA can be synthesized mutant peptides.
-
DescriptionH-Ala-Ala-Tyr-OH TFA can be synthesized mutant peptides.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[Arg8]-Vasotocin TFA
[Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.
-
Pomalidomide-PEG4-C2...
Pomalidomide-PEG4-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.
-
Hydroxygenkwanin
Hydroxygenkwanin has cytotoxicity, may be an effective natural product to treat glioma, and the combination of Apigenin and Hydroxygenkwanin may be a promising method for glioma chemotherapy.
